Experience of using Anifrolumab in the treatment of patients with systemic lupus erythematosus

The aim – evaluation of the efficacy and safety of anifrolumab (AFM) therapy in patients with severe and moderate systemic lupus erythematosus (SLE) in real clinical practice.Material and methods. A prospective observational study (6 months) involving 14 patients with SLE (13 women and 1 man; mean a...

Full description

Saved in:
Bibliographic Details
Main Authors: E. V. Bolotova, E. V. Jakovleva, E. K. Ilinykh, Т. A. Rassovskaya
Format: Article
Language:Russian
Published: IMA PRESS LLC 2025-03-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/3698
Tags: Add Tag
No Tags, Be the first to tag this record!